4
Changes in Ownership
LISATA THERAPEUTICS, INC. Filed Acc 0001879231-25-000002
EVP, R&D and CMO gave up 7,878 shares (to pay taxes)
- EVP, R&D and CMO acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Buck Kristen K · EVP, R&D and CMO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-09 | Grant or award : show line 1 in the form | +25,000 | 87,672 | D | ||
| 2025-01-09 | Shares withheld for taxes : show line 2 in the form | −2,651 | $3.80 | $10,074 | 85,021 | D |
| 2025-01-09 | Shares withheld for taxes : show line 3 in the form | −2,863 | $3.80 | $10,879 | 82,158 | D |
| 2025-01-09 | Shares withheld for taxes : show line 4 in the form | −1,908 | $3.80 | $7,250 | 80,250 | D |
| 2025-01-10 | Shares withheld for taxes : show line 5 in the form | −456 | $3.73 | $1,701 | 79,794 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-09 | Grant or award : show line 6 in the form Stock Option (Right to Buy) | +13,000 | 13,000 | D |
Loading xslF345X05/wk-form4_1736802577.xml…